Matinas BioPharma Holdings, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity (Details Narrative)

Stockholders’ Equity (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands				6 Months Ended
	Apr. 04, 2025	Feb. 13, 2025	Jul. 02, 2020	Jun. 30, 2026	Dec. 31, 2025	Aug. 15, 2025	Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]
Common stock, shares authorized				500,000,000	500,000,000
Preferred stock, shares authorized				10,000,000
Preferred stock, par value				$ 0.0001
Outstanding warrants				10,516,543	10,516,543		666,667
2024 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Outstanding warrants				200,001
Exercise price				$ 17.50
2025 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Outstanding warrants				10,316,542
Exercise price				$ 0.64
Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Outstanding warrants				10,516,543
Warrant [Member] \| 2025 Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Exercise price				$ 0.64
Series C Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred stock, shares authorized				10,000,000	10,000,000
Preferred stock, par value				$ 0.0001	$ 0.0001
Securities Purchase Agreement [Member] \| Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants to purchase aggregate of shares of common stock percentage		200.00%
Purchase of warrants		11,262,808
Securities Purchase Agreement [Member] \| Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Offering price per share		$ 1,000
Securities Purchase Agreement [Member] \| Series C Convertible Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Preferred stock, par value		$ 0.0001
Shares issued		3,300
Securities Purchase Agreement [Member] \| Common Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of preferred stock into common stock shares		5,631,404
Common stock, par value		$ 1,000
Exchange Agreement [Member] \| Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Purchase of warrants						466,666
Exchange Agreement [Member] \| April Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Purchase of warrants						466,666
Underwritten Public Offering [Member] \| Sales Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Aggregate offering price for sale of stock			$ 50,000	$ 44,191
Sale of stock percentage			3.00%
Initial Closing [Member] \| Securities Purchase Agreement [Member] \| Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants exercisable		5,631,404
Proceeds from issuance of warrants		$ 1,650
Initial Closing [Member] \| Securities Purchase Agreement [Member] \| Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued		1,650
Initial Closing [Member] \| Securities Purchase Agreement [Member] \| Common Stock and Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of preferred stock into common stock shares		2,815,702
Second Closing [Member] \| Securities Purchase Agreement [Member] \| Warrant [Member]
Subsidiary, Sale of Stock [Line Items]
Warrants exercisable	5,631,404
Proceeds from issuance of warrants	$ 1,650
Second Closing [Member] \| Securities Purchase Agreement [Member] \| Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shares issued	1,650
Second Closing [Member] \| Securities Purchase Agreement [Member] \| Common Stock and Warrants [Member]
Subsidiary, Sale of Stock [Line Items]
Conversion of preferred stock into common stock shares	2,815,702